On the heels of raising $44 million in a Series C Round, MediciNova Inc. filed with the SEC to raise $100 million in an initial public offering in Japan, where it was founded four years ago as a subsidiary of Tanabe Seiyaku Co. Ltd., of Osaka. (BioWorld Today) Read More